Immunotherapy News and Research

Latest Immunotherapy News and Research

Research programme to develop immunological biomarkers for chronic inflammatory diseases

Research programme to develop immunological biomarkers for chronic inflammatory diseases

Sangretech Biomedical signs amended license agreement with Bostwick Laboratories

Sangretech Biomedical signs amended license agreement with Bostwick Laboratories

Cytheris initiates Phase I/IIa dose escalation study of patients suffering from ICL

Cytheris initiates Phase I/IIa dose escalation study of patients suffering from ICL

Biosante Pharmaceuticals, Cell Genesys successfully complete merger

Biosante Pharmaceuticals, Cell Genesys successfully complete merger

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson announces financial results for the third quarter of 2009

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

HST Global announces alliance for R&D of Nutraceutical and Medical Food formulation platform

HST Global announces alliance for R&D of Nutraceutical and Medical Food formulation platform

Aging of the immune system coincides with higher rates of cancer in the elderly

Aging of the immune system coincides with higher rates of cancer in the elderly

Epitope spreading can get triggered by live, attenuated Listeria vaccine

Epitope spreading can get triggered by live, attenuated Listeria vaccine

Elderly cancer patients need custom-made treatment to combat the disease

Elderly cancer patients need custom-made treatment to combat the disease

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs

Celldex Therapeutics acquires CuraGen Corporation

Celldex Therapeutics acquires CuraGen Corporation

Advaxis announces Phase I trial results of its ADXS11-001 therapeutic cancer vaccine

Advaxis announces Phase I trial results of its ADXS11-001 therapeutic cancer vaccine

New treatment for Alzheimer's disease may be in the offing

New treatment for Alzheimer's disease may be in the offing

Researchers to use Intravenous Immune Globulin for slowing AD progression

Researchers to use Intravenous Immune Globulin for slowing AD progression

Opexa Therapeutics' endeavor in the field of stem cell technology

Opexa Therapeutics' endeavor in the field of stem cell technology

Cancer Research UK invests £16 million in new Drug Discovery Programes at Manchester and Glasgow

Cancer Research UK invests £16 million in new Drug Discovery Programes at Manchester and Glasgow

JANSSEN Alzheimer Immunotherapy acquires Elan

JANSSEN Alzheimer Immunotherapy acquires Elan

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.